Evidence map›Paper›PMID 28861505›Full record

ReviewCannabis and cannabinoid research2017

The Use of Cannabis for Headache Disorders.

Bryson C Lochte, Alexander Beletsky, Nebiyou K Samuel, Igor Grant

Open access · bronzeAbstract readReview
In one paragraph

Review in Cannabis and cannabinoid research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Medical Cannabis for Headache Pain: a Primer for Clinicians.Current pain and headache reports · 2021
    Review
  6. Nutraceuticals and Behavioral Therapy for Headache.Current neurology and neuroscience reports · 2021
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. [Cannabinoids in pain medicine].Schmerz (Berlin, Germany) · 2018
    Article
  13. Review
  14. Article
  15. Cannabis and pain: a scoping review.Brazilian journal of anesthesiology (Elsevier)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Bryson C LochteDepartment of Psychiatry, Center for Medicinal Cannabis Research, University of California, San Diego, La Jolla, California.
Alexander BeletskyDepartment of Psychiatry, Center for Medicinal Cannabis Research, University of California, San Diego, La Jolla, California.
Nebiyou K SamuelDepartment of Psychiatry, Center for Medicinal Cannabis Research, University of California, San Diego, La Jolla, California.
Igor GrantDepartment of Psychiatry, Center for Medicinal Cannabis Research, University of California, San Diego, La Jolla, California.
University of California, San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Headache disorders are common, debilitating, and, in many cases, inadequately managed by existing treatments. Although clinical trials of cannabis for neuropathic pain have shown promising results, there has been limited research on its use, specifically for headache disorders. This review considers historical prescription practices, summarizes the existing reports on the use of cannabis for headache, and examines the preclinical literature exploring the role of exogenous and endogenous cannabinoids to alter headache pathophysiology. Currently, there is not enough evidence from well-designed clinical trials to support the use of cannabis for headache, but there are sufficient anecdotal and preliminary results, as well as plausible neurobiological mechanisms, to warrant properly designed clinical trials. Such trials are needed to determine short- and long-term efficacy for specific headache types, compatibility with existing treatments, optimal administration practices, as well as potential risks.

Indexed as

cannabisheadachetherapy

Identifiers

PMID28861505
PMCPMC5436334
OpenAlexW2606215411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.